Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients
- 1 February 2002
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 160 (2) , 477-481
- https://doi.org/10.1016/s0021-9150(01)00608-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liverPublished by Elsevier ,2021
- Genetic basis of sitosterolemiaCurrent Opinion in Lipidology, 2001
- Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC TransportersScience, 2000
- Noncholesterol Sterols and Cholesterol Lowering by Long-Term Simvastatin Treatment in Coronary PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival studyBMJ, 1998
- Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic PopulationNew England Journal of Medicine, 1995
- Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1995
- SERUM PLANT STEROLS AND CHOLESTEROL PRECURSORS REFLECT CHOLESTEROL ABSORPTION AND SYNTHESIS IN VOLUNTEERS OF A RANDOMLY SELECTED MALE POPULATIONAmerican Journal of Epidemiology, 1990
- Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged menMetabolism, 1989
- Gas-liquid chromatographic determination of fecal neutral sterols using a capillary columnClinica Chimica Acta; International Journal of Clinical Chemistry, 1982